Brand-name drug prices rising at a slower pace
According to an Associated Press analysis, it found drug companies are still raising prices for brand-name prescription medicines, just not
Read MoreAccording to an Associated Press analysis, it found drug companies are still raising prices for brand-name prescription medicines, just not
Read More(By Alia Paavola for Becker’s Hospital Review) Roche has priced its cancer treatment Rozlytrek at $17,050 per month, about half
Read MoreIf you have Medicare and you’re facing financial challenges with paying for healthcare, Medicare Savings Programs may be able to
Read More(By Alia Paavola for Becker’s Hospital Review) Two lawmakers have accused three generic drugmakers of “coordinated obstruction” and “apparent efforts
Read MoreAccording to a new Government Accountability Office report, it found Pharmacy benefit managers negotiated $18 billion worth of rebates from
Read MoreIn a comprehensive study being conducted at the University of South Florida, the first ever medication to treat age-related hearing
Read MoreNearly 40 percent of people will eventually be diagnosed with some form of cancer at some time in their life
Read More(By Nicholas Florko and Lev Facher for STAT) WASHINGTON — Canadians are furious about the Trump administration’s plan to import their prescription
Read More(By Patrick Skerrett for STAT) In the conclusion of her recently published book, “Bottle of Lies,” Katherine Eban briefly notes
Read MoreRetiring overseas? You should know that except in very specific situations, basic Medicare does not cover medical services you get
Read More